Going beyond boundaries in structural heart interventions?
Sponsored by Abbott
- To gain perspective from thought leaders on how the cathlab will evolve over the next 5-10 years
- To participate to a unique discussion on the evolution of structural heart interventions
- To learn the preferred strategy for combined cardiac diseases: while a staged approach may represent a preferable strategy in selected patients, concomitant treatment of combined cardiac diseases represents an appealing option in a majority of patients
Transcatheter mitral valve replacement and repair: are new realities on the TMVR horizon?
Transcatheter tricuspid valve interventions in 2017: unmet needs and future perspectives